A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride

The purpose of the study is to investigate the relationship of changes in measures of academic performance and problem behaviors, to changes in core Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in Asian children treated with atomoxetine.

Inclusion Criteria:

• Male or female outpatients between 8 and 11 years of age at study entry
• Attention-Deficit/Hyperactivity Disorder (ADHD) meeting the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) disease diagnostic criteria
• Patients who have never received medications psychotropic medications specifically to treat ADHD, or if they have received medication, that the trial of the psychotropic medication(s) was of less than 1 month duration, and occurred more than 6 months prior to study entry
• Normal intelligence in the judgment of the investigator
• Must be able to swallow capsules

Exclusion Criteria:

• Current or past history of bipolar I or II disorder, psychosis, autism, Asperger's syndrome, pervasive developmental disorder, or conduct disorder
• History of seizure disorder or currently taking anticonvulsants for seizure control
• Serious suicidal risk as determined by investigator
• Cardiovascular disease; current or past history of hypertension
• Previous treatment with atomoxetine